Immune Checkpoint Inhibitor Use Near the End of Life: A Single-Center Retrospective Study

Overview of attention for article published in Journal of Palliative Medicine, November 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 2 news outlets

twitter: 47 X users

Readers on

mendeley: 34 Mendeley

So far, Altmetric has seen 52 X posts from 47 X users, with an upper bound of 176,912 followers.

@NicholasZaorsky Some other studies have also looked at this: 1. https://t.co/RguvrmWK9x 2.https://t.co/wBPT24D5JN 3. https://t.co/S6VpgMEKfr 4. https://t.co/KnDsah9sXv

Very welcomed study about the use of #Immunotherapy at the end of life. We must take care of not using a wonderful tool to offer #hope in a wrong time. #cancer #CancerResearch #science #clinicaltrials https://t.co/EkfylC1JpX

RT @RossFH: Important findings about the use of #immunotherapy near the end of life -- treatment within the last 30 or 90 days of life was…

On the list of to read articles @AbbyOttoMD @AnneTjadenMD #listgettinglonger #needtoreadfaster

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 48 additional X posts.